2011至2021年人工髋关节翻修术费用、收入与边际贡献趋势
该研究回顾性分析了2011年6月至2021年5月在本机构接受人工髋关节翻修术的1,613例患者,按保险类型分为联邦医疗保险(661例)、政府管理的医疗补助(449例)和商业保险(503例)三组,分析收入、直接成本、总成本和边际贡献(CM)随时间的变化。结果显示联邦医疗保险患者的收入、总成本和直接成本呈显著上升趋势(P值分别为<.001、.004、<.001),CM呈显著下降趋势(P=.037),至2021年CM降至2011年水平的72.1%。结论认为联邦医疗保险人群的翻修术报销未能匹配成本增长,导致CM大幅降低,影响医院覆盖间接成本的能力。
要点
- 联邦医疗保险患者翻修术收入、总成本和直接成本均呈显著上升趋势,P值分别为<.001、.004、<.001。
- 联邦医疗保险患者边际贡献呈显著下降趋势(P=.037),2021年降至2011年的72.1%。
- 商业保险和政府管理医疗补助组的趋势未在摘要中报告。
核心结论
- 在联邦医疗保险人群中,人工髋关节翻修术的报销未能匹配成本增长,导致边际贡献大幅降低。
- 这些趋势影响医院覆盖间接成本的能力,威胁需要该必要手术患者的就医可及性。
- 作者建议应重新考虑人工髋关节翻修术的报销模式,以确保所有患者人群的手术财务可行性。
研究设计与样本
- 回顾性研究,纳入2011年6月至2021年5月在本机构接受人工髋关节翻修术的所有患者1,613例。
- 按保险类型分组:联邦医疗保险661例、政府管理的医疗补助449例、商业保险503例。
- 收集人口学资料、收入、直接成本、总成本和边际贡献,以2011年数值的百分比分析随时间变化,采用线性回归分析趋势显著性。
主要发现
- 联邦医疗保险患者收入呈显著上升趋势(P<.001)。
- 联邦医疗保险患者总成本呈显著上升趋势(P=.004)。
- 联邦医疗保险患者直接成本呈显著上升趋势(P<.001)。
- 联邦医疗保险患者边际贡献呈显著下降趋势(P=.037),至2021年降至2011年数值的72.1%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Revision total hip arthroplasty (rTHA) is a costly procedure, and its prevalence has been steadily increasing over time. This study aimed to examine trends in hospital cost, revenue, and contribution margin (CM) in patients undergoing rTHA. METHODS: We retrospectively reviewed all patients who underwent rTHA from June 2011 to May 2021 at our institution. Patients were stratified into groups based on insurance coverage: Medicare, government-managed Medicaid, or commercial insurance. Patient demographics, revenue (any payment the hospital received), direct cost (any cost associated with the surgery and hospitalization), total cost (the sum of direct and indirect costs), and CM (the difference between revenue and direct cost) were collected. Changes over time as a percentage of 2011 numbers were analyzed. Linear regression analyses were used to determine the overall trend's significance. Of the 1,613 patients identified, 661 were covered by Medicare, 449 by government-managed Medicaid, and 503 by commercial insurance plans. RESULTS: Medicare patients exhibited a significant upward trend in revenue (P < .001), total cost (P = .004), direct cost (P < .001), and an overall downward trend in CM (P = .037), with CM for these patients falling to 72.1% of 2011 values by 2021. CONCLUSION: In the Medicare population, reimbursement for rTHA has not matched increases in cost, leading to considerable reductions in CM. These trends affect the ability of hospitals to cover indirect costs, threatening access to care for patients who require this necessary procedure. Reimbursement models for rTHA should be reconsidered to ensure the financial feasibility of these procedures for all patient populations.
引用
- Ashkenazi I, Christensen T, Oakley C, et al. Trends in Revision Total Hip Arthroplasty Cost, Revenue, and Contribution Margin 2011 to 2021. J Arthroplasty. 2023. PMID: 37019310. doi:10.1016/j.arth.2023.03.088
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。